Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

US cancer vaccine market to increase at a CAGR of 5.3%

Industry Sector

Healthcare and Medical

Published

20 September 2012

Author

Mike King

Type of News

Market

The US cancer vaccine market has been forecast to increase at a compound annual growth rate (CAGR) of 5.3% over the next six years, increasing from a 2010 value of US$12.8 billion, to be worth US$17.4 billion by 2018.

The US cancer vaccine market is a growing market with great opportunities for entry. Approximately 1.5 million Americans are being diagnosed with cancer annually, and the annual overall cost of the disease is estimated to be $230 billion.

Cancer vaccines are highly researched today owing to growing cancer incidences and an urgent need to control and prevent the massively penetrating disease. Of this industry, the US represents a 49% share of the global cancer vaccines market.

The prophylactic vaccines currently available to the market include Merck's Gardasil, GSK's Cervarix, and several other Hepatitis B vaccines, while the only therapeutic vaccine in the market is Dendreon's Provenge.

Therapeutic vaccines currently account for approximately a 15% share of the US cancer vaccine market but this is expected to increase drastically post 2016 with such high focus on developing therapeutics for other cancer types.

Merck and GSK are expected to continue to be undefeated market leaders in the prophylactic cancer segment as the launch of a new cancer vaccine is unlikely in the next three years.

For more information on the US cancer vaccine market, see the latest research: US Cancer Vaccine Market Report

Follow us on Twitter @CandMResearch

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

December Discounted Prices: Contact us to ask about our special discounts available in December

For the last month in 2014 we are offering discounted prices on a selection of new reports. Please contact us on 00 44 (0) 203 0868600 or via email (click here to email) to ask about prices and special discounts.

Available during December and the run-up to Christmas; Discounted prices on a selection of our reports.

Find all the research at the best prices. Great promotions being offered during December!

We are offering our clients substantial savings on the best research available during December. Please contact us either via emailor by calling our team to discuss your specific research needs on Tel: 00 44 (0) 203 0868600. We look forward to being able to find you the research you require at good prices.

Accessibility
Close

Contrast settings

Text size settings